Literature DB >> 24940142

Chorea in a chronic pain patient using gabapentin.

Dmitri Souzdalnitski1, Anita Kumar Chang2, Maged Guirguis3.   

Abstract

BACKGROUND: Gabapentin increasingly is being used to treat chronic pain in addition to seizures, anxiety, and bipolar disorder. Chorea has been reported as a potential side effect of gabapentin. CASE REPORT: We report the case of a patient with chronic low back pain who was treated with a host of modalities, including gabapentin. After she increased her dose of gabapentin, she developed chorea of the upper extremities, neck, and head. With cessation of gabapentin, the bulk of her symptoms resolved within 24 hours, and symptoms completely resolved in the following months.
CONCLUSIONS: Chorea is thought to appear when the basal ganglia are deregulated. Gabapentin interferes with gamma-aminobutyric acid, the primary inhibitory neurotransmitter in the motor pathway. Chorea associated with gabapentin has been reported in several case studies, but not at a dose as low as the patient took in this case.

Entities:  

Keywords:  Basal ganglia; chorea; chronic pain; drug-related side effects and adverse reactions; gabapentin; gamma-aminobutyric acid

Year:  2014        PMID: 24940142      PMCID: PMC4052599     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  10 in total

1.  Intrathecal gabapentin and clonidine synergistically inhibit allodynia in spinal nerve-ligated rats.

Authors:  Yoshihiro Yamama; Kiyonobu Nishikawa; Tomoharu Funao; Takashi Mori; Akira Asada
Journal:  Life Sci       Date:  2010-09-24       Impact factor: 5.037

2.  Chorea due to gabapentin monotherapy in a not encephalopatic patient.

Authors:  Carlos Alexandre Twardowschy; Hélio Afonso Ghizoni Teive; Artur Furlaneto Fernandes; Ismael Paulo Búrigo; Marcos Lange; Lineu César Werneck
Journal:  Arq Neuropsiquiatr       Date:  2008-03       Impact factor: 1.420

3.  Choreoathetotic movements: A possible side effect of gabapentin.

Authors:  C M Buetefisch; A Gutierrez; L Gutmann
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Synergic antinociceptive interaction between tramadol and gabapentin after local, spinal and systemic administration.

Authors:  Vinicio Granados-Soto; Carlos F Argüelles
Journal:  Pharmacology       Date:  2005-05-10       Impact factor: 2.547

6.  Choreoathetosis as a side effect of gabapentin therapy in severely neurologically impaired patients.

Authors:  R S Chudnow; R B Dewey; C R Lawson
Journal:  Arch Neurol       Date:  1997-07

Review 7.  The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns.

Authors:  Jonathan W Mink
Journal:  Arch Neurol       Date:  2003-10

8.  Chorea associated with gabapentin use in an elderly man.

Authors:  Reji Attupurath; Rehan Aziz; Daniel Wollman; Sunanda Muralee; Rajesh R Tampi
Journal:  Am J Geriatr Pharmacother       Date:  2009-08

Review 9.  Mechanisms of action of gabapentin.

Authors:  C P Taylor
Journal:  Rev Neurol (Paris)       Date:  1997       Impact factor: 2.607

10.  Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1.

Authors:  Theresa A Zesiewicz; W Reed Shimberg; Robert A Hauser; Wendy Robinson; Maria-Carmen Wilson; Kelly L Sullivan
Journal:  Clin Rheumatol       Date:  2007-10-16       Impact factor: 2.980

  10 in total
  1 in total

Review 1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2014
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.